HEALTHX305.00

Health X Platform Limited

· Pharma & Health
₹ CrorePeersSURAKSHAKRSNAANEPHROPLUS3BBLACKBIOMcap ₹970 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.110.690.610.85
Interest Burden (Pretax/EBIT) ×-14.963.120.040.41
EBIT Margin %-0.27-5.57-4.45-5.03
Asset Turnover ×1.201.141.411.41
Financial Leverage (Assets/Equity) ×1.151.131.221.22
ROE (5-step product) %0.59-15.44-0.19-3.06
ROE (reported, avg-equity basis) %0.89-10.550.150.15
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.